Why Cigna Made This Decision for Its Own Employees The decision that we made in our employee benefit plan is driven by the exact same set of challenges that many of our clients are facing, specifically where the net cost of the drug is straining the overall affordability of the plan, Evanko said
The risk of DKA is dependent on the dose, and is also less in people with overweight and higher doses of insulin, Mathieu explained
This accords with recent trial evidence, through which semaglutide was shown to reduce remodeling in patients with obesity-associated heart failure
14 Finally, embarking on this journey with the guidance of a supportive healthcare team, including a physician and ideally a registered dietitian nutritionist, is strongly recommended
If the latter, then any strain might not appear in GLP-1 supply itself, but could instead become apparent elsewhere in the portfolio